Guardion Health Adopts Dissolution, Liquidation Plan; Appoints Interim CEO -- Shares Fall

MT Newswires Live10-01

Guardion Health Sciences (GHSI) said Tuesday it intends to delist its common shares from the Nasdaq Capital Market in connection with its plan of liquidation and dissolution, with the official delisting expected to be effective Oct. 21.

The company expects to pay its shareholders a liquidating dividend in an amount that is anticipated to total about $3.25 per share.

Guardion said it also plans to seek no-action relief from the US Securities and Exchange Commission "as soon as practicable" in order to indefinitely suspend its reporting obligations.

The company has named board member Mark Goldstone as interim chief executive and interim president, effective Oct. 18, succeeding CEO and President Jan Hall, who has left the company, it said.

Guardion Health shares were down nearly 43% in recent trading.

Price: 3.13, Change: -2.42, Percent Change: -43.59

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment